Families
Research
Investors
Investor center
Why invest in BlinkLab?
Analyst coverage
ASX announcements
Leadership & governance
Financial overview
FDA regulatory pipeline
Media & investor resources
Investor inquiries
About us
Our team
Partnerships
BlinkLab news
Media mentions
Careers
Contact us
Join our study
No quick results
Hit ‘enter’ to search full site for “
Search query
”
Investors
Investor center
ASX announcements
Analyst Coverage
Why invest
Leadership & governance
Financial overview
Media & Resources
Regulatory Pipeline
Investor inquiries
Families
For families
Instruction
Participate
About Us
Our team
Partnerships
BlinkLab news
Media mentions
Careers
Contact us
Hit enter to search
Home
Investors
Analyst Coverage
Analyst coverage
August 2026
Bioshares, Australia's Independent Biotech Investment Resource
August 2026
ADHD Breakthrough Expands the Opportunity | Autism Dx1 Advances Towards FDA Approval
May 2026
Morgans Financial - Initiation: "Blink and you will miss important milestones"
January 2026
Lodge Partners Research Update - Pilot Study Confirms Path to Commerciality
April 2026
Bioshares, Australia's Independent Biotech Investment Resource
March 2026
Bioshares, Australia's Independent Biotech Investment Resource
November 2025
Outstanding USA Pilot Results Set the Path for 2026 FDA Clearance
October 2025
Bioshares, Australia's Independent Biotech Investment Resource
October 2024
Lodge Partners - Initiation Research Report - BlinkLab Ltd (ASX:BB1) ASD & ADHD Diagnostic App
March 2024
Bioshares, Australia’s Independent Biotech Investment Resource
